tiprankstipranks
Trending News
More News >
CE Holdings Co., Ltd. (JP:4320)
:4320
Japanese Market
Advertisement

CE Holdings Co., Ltd. (4320) AI Stock Analysis

Compare
0 Followers

Top Page

JP:4320

CE Holdings Co., Ltd.

(4320)

Select Model
Select Model
Select Model
Outperform 74 (OpenAI - 4o)
Rating:74Outperform
Price Target:
¥1,243.00
▲(17.04% Upside)
The overall stock score of 74 reflects strong technical momentum and a solid financial foundation. The company's robust revenue growth and operational efficiency are significant strengths, although profitability and cash flow consistency need improvement. The stock's valuation is reasonable, but the high RSI and Stochastic indicators suggest caution due to potential overbought conditions.

CE Holdings Co., Ltd. (4320) vs. iShares MSCI Japan ETF (EWJ)

CE Holdings Co., Ltd. Business Overview & Revenue Model

Company DescriptionCE Holdings Co., Ltd., through its subsidiaries, develops and sells electronic medical record systems and medical information systems in Japan. The company provides MI RA Is (Miraize), an electronic medical record system for medical institutions. The company was formerly known as CEI Corporation and changed its name to CE Holdings Co., Ltd. in April 2013. CE Holdings Co., Ltd. was incorporated in 1996 and is based in Sapporo, Japan.
How the Company Makes MoneyCE Holdings generates revenue through multiple streams, including rental income from its real estate properties, capital gains from property sales, and returns on investments in technology startups. The company also earns revenue from the distribution of consumer goods, partnering with manufacturers to bring products to market. Significant partnerships with tech firms and real estate developers enhance its investment portfolio, allowing for diversification and risk management. Additionally, CE Holdings capitalizes on market trends to make strategic acquisitions, further boosting its earnings potential.

CE Holdings Co., Ltd. Financial Statement Overview

Summary
CE Holdings Co., Ltd. demonstrates strong revenue growth and operational efficiency, particularly in EBIT and EBITDA margins. The balance sheet is robust with low leverage and high equity ratios, but profitability and return on equity require improvement. Cash flow performance is inconsistent, necessitating focus on enhancing cash generation. Overall, the financial footing is stable with opportunities to boost returns.
Income Statement
72
Positive
The company has demonstrated consistent revenue growth over the years, with a notable increase from 2020 to 2024. The TTM revenue of 15,180 million yen marks a healthy growth from the previous period. Gross profit margin stands at 23.0% for TTM, indicating efficient cost management. However, the net profit margin is relatively low at 1.8% for TTM, suggesting room for improvement in profitability. EBIT and EBITDA margins are robust at 8.9% and 11.4% respectively, showcasing strong operational performance.
Balance Sheet
80
Positive
The company's balance sheet is stable with a favorable equity position. The debt-to-equity ratio is a conservative 0.33, reflecting prudent financial leverage. ROE for TTM is low at 4.6%, indicating modest returns on equity. The equity ratio is strong at 54.6%, highlighting solid capitalization and low reliance on debt. Overall, the company maintains a healthy balance sheet with good liquidity and low financial risk.
Cash Flow
60
Neutral
Cash flow metrics show mixed results. While there is no reported free cash flow for the TTM, historical data indicate fluctuations. Operating cash flow was positive in prior years, but the recent absence of data limits comprehensive analysis. The free cash flow to net income ratio was modest in previous periods, suggesting potential efficiency improvements in cash flow generation.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue15.96B14.55B13.63B13.70B12.28B10.60B
Gross Profit3.76B3.37B3.69B3.16B2.65B2.02B
EBITDA2.24B1.24B1.71B1.44B1.36B732.22M
Net Income945.86M123.42M687.53M588.00M632.93M121.45M
Balance Sheet
Total Assets12.29B11.25B11.24B10.91B9.46B8.86B
Cash, Cash Equivalents and Short-Term Investments5.38B3.83B3.14B3.96B2.87B2.81B
Total Debt1.60B2.16B1.42B1.89B1.37B2.10B
Total Liabilities4.51B4.65B4.66B4.82B3.98B4.02B
Stockholders Equity7.27B6.10B6.08B5.63B5.07B4.50B
Cash Flow
Free Cash Flow569.00M89.90M-46.35M45.64M613.91M567.46M
Operating Cash Flow629.00M752.30M795.82M1.55B1.00B912.58M
Investing Cash Flow-237.00M-630.41M-861.72M-763.83M-109.39M-68.24M
Financing Cash Flow-340.00M566.46M-754.51M306.64M-838.45M573.79M

CE Holdings Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1062.00
Price Trends
50DMA
827.37
Positive
100DMA
746.85
Positive
200DMA
674.60
Positive
Market Momentum
MACD
79.86
Negative
RSI
71.01
Negative
STOCH
72.79
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4320, the sentiment is Positive. The current price of 1062 is above the 20-day moving average (MA) of 943.70, above the 50-day MA of 827.37, and above the 200-day MA of 674.60, indicating a bullish trend. The MACD of 79.86 indicates Negative momentum. The RSI at 71.01 is Negative, neither overbought nor oversold. The STOCH value of 72.79 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4320.

CE Holdings Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
¥9.57B14.787.54%26.12%38.78%
¥15.96B14.262.07%7.79%38592.95%
¥15.32B10.150.65%-17.86%133.08%
¥22.81B22.431.56%13.39%12.00%
¥7.57B-2.60%-103.03%
$7.86B-0.30-43.30%2.27%22.53%-2.21%
¥17.78B-24.301.47%-0.58%-260.22%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4320
CE Holdings Co., Ltd.
1,062.00
641.21
152.38%
JP:3628
Data Horizon Co., Ltd.
640.00
262.00
69.31%
JP:3671
Softmax Co., Ltd. (Japan)
398.00
190.12
91.46%
JP:3902
Medical Data Vision Co.Ltd.
442.00
-71.05
-13.85%
JP:3939
Kanamic Network Co., LTD.
481.00
-46.76
-8.86%
JP:6095
MedPeer, Inc.
696.00
123.00
21.47%

CE Holdings Co., Ltd. Corporate Events

CE Holdings Co., Ltd. Reports Strong Financial Performance for Nine Months Ending June 2025
Aug 15, 2025

CE Holdings Co., Ltd. reported a significant improvement in its financial performance for the nine months ending June 30, 2025, with net sales increasing by 12.8% and operating profit surging by 68.9% compared to the previous year. The company’s strong performance is attributed to effective management strategies and market conditions, positioning it favorably for future growth. The forecast for the full year ending September 30, 2025, anticipates continued growth, with expected increases in net sales and profits, reflecting the company’s robust financial health and strategic focus.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 24, 2025